Clinical Study

Botox For The Prevention Of Migraine In Patients With Episodic Migraine

Posted Date: Sep 20, 2021

  • Investigator: Lesley Arnold
  • Specialties: Pain Medicine, Psychiatry/Psychology
  • Type of Study: Drug

The objective of this study is to evaluate the efficacy and safety of 2 dose levels of BOTOX compared with placebo as migraine prevention in subjects with Episodic Migraine.


Adult Male Or Female, 18 To 65 Years Old


Migraine, Headache, Botox

For More Information:

Lesley Arnold

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.